Clover Biopharmaceuticals, Ltd. Stock
Stocks
2197
KYG2280A1076
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.130 HKD | -0.70% |
|
+29.09% | -8.97% |
| Market Cap | 2.4B 2.78B 355M 309M 288M 264M 499M 33.84B 507M 3.4B 1.33B 16.88B 1.33B 1.3B 55.66B | P/E 2024 |
-0.31x | P/E 2025 | -12.9x |
|---|---|---|---|---|---|
| Enterprise Value | 2.13B 2.47B 315M 274M 255M 235M 442M 30.01B 450M 3.01B 1.18B 14.97B 1.18B 1.16B 49.36B | EV / Sales 2024 |
-849,529x | EV / Sales 2025 | 701,122,231x |
| Free-Float |
53.18% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.70% | ||
| 1 week | +29.09% | ||
| Current month | +6.50% | ||
| 1 month | +24.56% | ||
| 3 months | -26.04% | ||
| 6 months | -5.75% | ||
| Current year | -8.97% |
| 1 week | 1.64 |  | 2.31 |
| 1 month | 1.4 | | 2.31 |
| Current year | 1.32 | | 3.2 |
| 1 year | 0.54 | | 3.2 |
| 3 years | 0.18 | | 3.2 |
| 5 years | 0.18 | | 14.8 |
| 10 years | 0.18 | | 14.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
G. Joshua Liang
CEO | Chief Executive Officer | - | 2020-12-24 |
Aileen Wang
DFI | Director of Finance/CFO | - | 2022-06-30 |
Htay Htay Han
CTO | Chief Tech/Sci/R&D Officer | 58 | 2021-02-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Peng Liang
CHM | Chairman | 65 | 2018-10-30 |
G. Joshua Liang
BRD | Director/Board Member | - | 2020-12-24 |
Xiao Dong Wang
BRD | Director/Board Member | 62 | 2021-03-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/16/26 | Other | Chairman | -500,000 | 0.0385% | ||
| 7/10/26 | Other | Chairman | -50,000 | 0.0039% | ||
| 7/2/26 | Other | Chairman | -50,000 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.70% | +29.09% | +287.27% | +117.35% | 355M | |
| +0.05% | +3.08% | +38.17% | +66.77% | 56.7B | |
| +0.61% | -5.93% | +23.59% | +62.24% | 51.97B | |
| +1.84% | +1.27% | -14.06% | -13.50% | 23.33B | |
| -0.15% | -6.00% | -9.42% | +344.47% | 21.34B | |
| +1.68% | -2.07% | +32.14% | -26.18% | 17.44B | |
| +9.91% | -2.51% | +188.84% | +326.19% | 14.77B | |
| +3.83% | -1.34% | +47.77% | +165.22% | 13.84B | |
| +1.61% | +0.56% | +439.92% | +166.12% | 12.12B | |
| +3.14% | -12.56% | +59.51% | +149.39% | 11.14B | |
| Average | +2.17% | +1.06% | +109.38% | +135.81% | 22.3B | |
| Weighted average by Cap. | +1.58% | -1.89% | +58.15% | +109.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 38.42 44.59 5.69 4.94 4.61 4.24 7.99 542.02 8.13 54.41 21.31 270.3 21.36 20.89 891.53 | 3.5 4.07 0.52 0.45 0.42 0.39 0.73 49.45 0.74 4.96 1.94 24.66 1.95 1.91 81.34 |
| Net income | -903M -1.05B -134M -116M -109M -99.61M -188M -12.75B -191M -1.28B -501M -6.36B -502M -491M -20.96B | -205M -238M -30.36M -26.38M -24.63M -22.61M -42.64M -2.89B -43.38M -290M -114M -1.44B -114M -111M -4.76B |
| Net Debt | -326M -379M -48.31M -41.99M -39.2M -35.98M -67.85M -4.6B -69.03M -462M -181M -2.3B -181M -177M -7.57B | -272M -315M -40.21M -34.94M -32.62M -29.95M -56.47M -3.83B -57.45M -385M -151M -1.91B -151M -148M -6.3B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | HK$2.130 | -0.70% | 4,162,000 |
| 26-08-03 | HK$2.145 | +7.25% | 11,935,590 |
| 26-07-31 | HK$2.000 | +14.29% | 11,925,000 |
| 26-07-30 | HK$1.750 | +4.79% | 4,502,000 |
| 26-07-29 | HK$1.670 | +1.21% | 1,965,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2197 Stock
Select your edition
All financial news and data tailored to specific country editions
